Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Recruiting · NCT06424301 · Registry updated 2025-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma | Eye Diseases, Hereditary, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, eye disorder, neoplasm, neuroepithelial neoplasm, ocular cancer, primitive neuroectodermal tumor, retinal cancer, retinal disorder, retinoblastoma | Recruiting | Early phase 1 | 2025-06-26 | NCT06424301 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eye & ENT Hospital of Fudan University | 64 |
| The Eye Hospital of Wenzhou Medical University | 15 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan Eye & ENT Hospital | Shanghai | China | 3 |